CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Open-market sale Chief Financial Officer sold 2,783 shares at $5.35 ($14,889)
- 4 Open-market sale Chief Financial Officer sold 2,783 shares at $5.56 ($15,472)
- 4 Open-market sale Chief Financial Officer sold 2,783 shares at $6.09 ($16,946)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion President and CEO acquired 40,000 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 2,783 shares at $7.24 ($20,141)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Medical Officer sold 50,000 shares at $7.52 ($376,055)
- 4 Open-market sale Chief Financial Officer sold 50,000 shares at $7.50 ($375,005)
- 4 Exercise or conversion Chief Commercial Officer acquired 18,750 shares (option exercise)
- 4 Open-market sale Chief Medical Officer sold 35,416 shares at $7.20 ($255,016)
- 4 Open-market sale Chief Financial Officer sold 2,783 shares at $6.96 ($19,372)
- 4 Exercise or conversion Chief Scientific Officer acquired 35,000 shares (option exercise)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 16 of 36 · 701 filings